Study of Anatomo-functional Correlation of the Upper Airways
P3E
2 other identifiers
interventional
100
1 country
1
Brief Summary
Sleep apnea-hypopnea syndrome (SAHS) is a disorder of nocturnal ventilation due to the occurrence abnormally frequent pauses in breathing. It is a public health problem that currently affects 13 % of men and 6% of women between 30 and 70 years old. Sleep apneas are conventionally divided into obstructive and central apneas, depending on the persistence or no respiratory movements and the existence or not pharyngeal collapse during apnea. There are upper airway characterization studies (VAS) in patients with syndrome sleep apnea/hypopnea (OSAS). These physiological characterization studies (measurement of critical closing pressure (Pcrit) of the VAS) and anatomical (transcutaneous ultrasound of the muscles of the floor of the mouth, the base of the tongue, or by a acoustic pharyngometry of the VAS) are interested separately to different parameters without searching correlation with the severity of sleep apnea nor their potential as a screening tool for OSAS in patients at risk. The investigators hypothesize that a strong correlation and constant exists between the physiological collapsibility of VAS, the anatomical measurements of the VAS and the degree of severity of OSAS. Thus, the aim of this descriptive study is to characterization as complete as possible of the VAS of apneic patients in a homogeneous population and a better understanding of the pathophysiological obstructive events in patients without factor obvious risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 7, 2023
CompletedFirst Submitted
Initial submission to the registry
February 22, 2023
CompletedFirst Posted
Study publicly available on registry
March 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedAugust 3, 2023
August 1, 2023
6 months
February 22, 2023
August 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
measure of the values of critical closing pressure of the upper airway
during procedure
The measurements in cm of tissus thickness of the upper airways by ultrasound
during procedure
measure the cross-sectional area of the upper airway by a acoustic pharyngometry
during procedure
Secondary Outcomes (5)
measure of pharyngeal volume by ultrasound
during procedure
measure of pharyngeal collapsibility by ultrasound
during procedure
predictive value (Sp, Se) of acoustic pharyngometry measurements
during procedure
predictive value of ultrasound measurements (Sp, Se)
during procedure
measure of apnea hypopnea index by polysomnography
during procedure
Study Arms (1)
Suspicion of sleep apnea syndrome
EXPERIMENTALAll patients, consulting Bichat sleep center for suspected sleep apnea syndrome
Interventions
The Pcrit will be measured on an automatic controlled device specially designed by the engineers of the inserm neophen team capable of varying the pressures from +4 to -20 centimeters of water, by a nasal mask whose pressures are connected to a pneumotachograph. The measurements will be performed in supine position.
Acoustic pharyngometry is an non-invasive technique consisting of the propagation of an acoustic wave from the lips to the larynx providing information on the lengths, cross-sectional areas and volumes of the air spaces.
Airway ultrasound is a non-invasive imaging allowing visualization and measurements of the tongue base and retrovascular fatty infiltration. Its main interest remains the evaluation of the tongue base which is clinically difficult.
Eligibility Criteria
You may qualify if:
- Patient for whom an PSG are prescribed as part of care
You may not qualify if:
- Pregnancy in progress (declared)
- Pulsed oxyhaemoglobin saturation \< 88% at rest on awakening
- Allergy to ultrasound gel
- Patient with difficulties in understanding the French language
- Vulnerable patient (guardianship, curators)
- Lack of affiliation to a social security scheme
- Lack of information and collection of informed, written and signed consent
- Patient under AME
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Bichat-Claude Bernard
Paris, 75018, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie-Pia d'Ortho, MD. Ph.D
Assistance Publique - Hôpitaux de Paris (AP-HP)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2023
First Posted
March 17, 2023
Study Start
February 7, 2023
Primary Completion
July 31, 2023
Study Completion
September 1, 2024
Last Updated
August 3, 2023
Record last verified: 2023-08